Healthcare provider profile · identity verified

Ryan Menchaca, MD

Family Practice · SAN ANTONIO, TX · NPI 1790215259

Profile state: partd only Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

We did not find matching Open Payments records for this doctor in 2025.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

We did not find matching Open Payments records for this doctor in the selected program year.

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Analysis 1 · Payment-linked products

Products named in Open Payments records

No payment-linked product analysis is available because no matching General Payment records were found for the selected year.

Public prescribing for products named in payments

There is no explicit payment-product set available for a Part D comparison.

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

There is no payer-company set available for this comparison.

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Atorvastatin Calcium	Atorvastatin Calcium	260	127
Rosuvastatin Calcium	Rosuvastatin Calcium	187	90
Lisinopril	Lisinopril	149	68
Amlodipine Besylate	Amlodipine Besylate	145	65
Levothyroxine Sodium	Levothyroxine Sodium	139	63
Omeprazole	Omeprazole	110	51
Tamsulosin Hcl	Tamsulosin Hcl	94	44
Gabapentin	Gabapentin	90	46
Losartan Potassium	Losartan Potassium	89	45
Hydrochlorothiazide	Hydrochlorothiazide	76	36
Metoprolol Succinate	Metoprolol Succinate	72	33
Pravastatin Sodium	Pravastatin Sodium	72	32
Sertraline Hcl	Sertraline Hcl	65	29
Lisinopril-Hydrochlorothiazide	Lisinopril/Hydrochlorothiazide	64	28
Metformin Hcl Er	Metformin Hcl	64	32
Duloxetine Hcl	Duloxetine Hcl	62	35
Diclofenac Sodium	Diclofenac Sodium	58	33
Montelukast Sodium	Montelukast Sodium	57	29
Simvastatin	Simvastatin	57	29
Alendronate Sodium	Alendronate Sodium	53	23
Furosemide	Furosemide	51	25
Metformin Hcl	Metformin Hcl	49	26
Trazodone Hcl	Trazodone Hcl	49	22
Losartan-Hydrochlorothiazide	Losartan/Hydrochlorothiazide	47	17
Pantoprazole Sodium	Pantoprazole Sodium	45	28
Mounjaro	Tirzepatide	41	12
Carvedilol	Carvedilol	40	21
Finasteride	Finasteride	40	17
Pioglitazone Hcl	Pioglitazone Hcl	39	16
Ozempic	Semaglutide	34	17
Metoprolol Tartrate	Metoprolol Tartrate	33	17
Atenolol	Atenolol	32	14
Fluticasone Propionate	Fluticasone Propionate	32	22
Albuterol Sulfate Hfa	Albuterol Sulfate	29	16
Escitalopram Oxalate	Escitalopram Oxalate	29	16
Famotidine	Famotidine	29	19
Allopurinol	Allopurinol	28	12
Farxiga	Dapagliflozin Propanediol	28	suppressed
Cyclobenzaprine Hcl	Cyclobenzaprine Hcl	27	12
Pregabalin	Pregabalin	27	15
Valsartan	Valsartan	27	14
Ezetimibe	Ezetimibe	26	13
Rybelsus	Semaglutide	26	suppressed
Mirtazapine	Mirtazapine	25	suppressed
Synthroid	Levothyroxine Sodium	25	suppressed
Donepezil Hcl	Donepezil Hcl	24	11
Potassium Chloride	Potassium Chloride	23	12
Clopidogrel	Clopidogrel Bisulfate	22	11
Glipizide Er	Glipizide	21	13
Tizanidine Hcl	Tizanidine Hcl	20	15
Clonazepam	Clonazepam	19	suppressed
Glimepiride	Glimepiride	19	suppressed
Azelastine Hcl	Azelastine Hcl	18	suppressed
Triamcinolone Acetonide	Triamcinolone Acetonide	18	15
Buspirone Hcl	Buspirone Hcl	17	suppressed
Esomeprazole Magnesium	Esomeprazole Magnesium	17	suppressed
Jardiance	Empagliflozin	17	suppressed
Spironolactone	Spironolactone	17	12
Eliquis	Apixaban	16	suppressed
Trulicity	Dulaglutide	16	suppressed
Bupropion Xl	Bupropion Hcl	15	suppressed
Citalopram Hbr	Citalopram Hydrobromide	15	suppressed
Lantus Solostar	Insulin Glargine,hum.Rec.Anlog	15	suppressed
Lovastatin	Lovastatin	15	suppressed
Memantine Hcl	Memantine Hcl	15	suppressed
Propranolol Hcl	Propranolol Hcl	15	suppressed
Xarelto	Rivaroxaban	15	suppressed
Eszopiclone	Eszopiclone	14	suppressed
Hydroxyzine Hcl	Hydroxyzine Hcl	14	suppressed
Meloxicam	Meloxicam	14	suppressed
Promethazine Hcl	Promethazine Hcl	14	suppressed
Ropinirole Hcl	Ropinirole Hcl	14	suppressed
Aripiprazole	Aripiprazole	13	suppressed
Benazepril Hcl	Benazepril Hcl	13	suppressed
Enalapril Maleate	Enalapril Maleate	13	suppressed
Fluoxetine Hcl	Fluoxetine Hcl	13	suppressed
Ibuprofen	Ibuprofen	13	suppressed
Naproxen	Naproxen	13	suppressed
Olmesartan Medoxomil	Olmesartan Medoxomil	13	suppressed
Chlorthalidone	Chlorthalidone	12	suppressed
Hydrocodone-Acetaminophen	Hydrocodone/Acetaminophen	12	suppressed
Alprazolam	Alprazolam	11	suppressed
Crestor	Rosuvastatin Calcium	11	suppressed
Fenofibrate	Fenofibrate Nanocrystallized	11	suppressed
Fluticasone-Salmeterol	Fluticasone Propion/Salmeterol	11	suppressed
Irbesartan	Irbesartan	11	suppressed
Prednisone	Prednisone	11	suppressed
Temazepam	Temazepam	11	suppressed
Valsartan-Hydrochlorothiazide	Valsartan/Hydrochlorothiazide	11	suppressed

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	—	—	—	—	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error